Frontal and associative visual areas related to visual hallucinations in dementia with lewy bodies and Parkinson's disease with dementia

Movement Disorders

Volumn 25, Issue 5, 2010, Pages 615-622

  Sanchez Castaneda, Cristina ^a,b   Rene, Ramon ^a   Ramirez Ruiz, Blanca ^b   Campdelacreu, Jaume ^a   Gascon, Jordi ^a   Falcon, Carles ^b   Calopa, Matilde ^a   Jauma, Serge ^a   Juncadella, Montserrat ^a   Junque, Carme ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dementia; Lewy body disease; MRI; Parkinson's disease; VBM; Visual hallucinations

Indexed keywords

AGED; ARTICLE; ATTENTION; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; GRAY MATTER; HUMAN; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; VISION; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; STATISTICS AS TOPIC;

EID: 77951210075     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22873     Document Type: Article

References (48)

1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
2. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39:165-172.
3. Mosimann UP, Rowan EN, Partington CE, et al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am J Geriatr Psychiatry 2006;14:153-160.
4. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-733.
5. Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001;16:528-536.
6. McKeith IG, Mosimann UP. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 2004;10 (Suppl 1):S15-S18.
7. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.
8. Diederich NJ, Fenelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol 2009;5:331-342.
9. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005;28:737-757.
10. Barnes J, Boubert L. Executive functions are impaired in patients with Parkinson's disease with visual hallucinations. J Neurol Neurosurg Psychiatry 2008;79:190-192.
11. Santangelo G, Trojano L, Vitale C, et al. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord 2007;22:2418-2425.
12. Grossi D, Trojano L, Pellecchia MT, Amboni M, Fragassi NA, Barone P. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. Int J Geriatr Psychiatry 2005;20:668-673.
13. Nagano-Saito A, Washimi Y, Arahata Y, et al. Visual hallucination in Parkinson's disease with FDG PET. Mov Disord 2004;19:801-806.
14. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005;20:130-140.
15. Barnes J, Boubert L, Harris J, Lee A, David AS. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 2003;41:565-574.
16. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738.
17. Klein C, Kompf D, Pulkowski U, Moser A, Vieregge P. A study of visual hallucinations in patients with Parkinson's disease. J Neurol 1997;244:371-377.
18. Matsui H, Udaka F, Tamura A, et al. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Geriatr Psychiatry Neurol 2006;19:36-40.
19. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007;14:750-756. (Pubitemid 47012171)
20. Perneczky R, Drzezga A, Boecker H, Forstl H, Kurz A, Haussermann P. Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 2008;25:531-538.
21. O'Brien JT, Colloby SJ, Pakrasi S, et al. Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage 2008;40:1056-1063.
22. O'Brien JT, Firbank MJ, Mosimann UP, Burn DJ, McKeith IG. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res 2005;139:79-88.
23. Higuchi M, Tashiro M, Arai H, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000;162:247-256.
24. Mori E, Shimomura T, Fujimori M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000;57:489-493.
25. Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola F, Tolosa E. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement Geriatr Cogn Disord 2007;23:281-288. (Pubitemid 46631933)
26. Imamura K, Wada-Isoe K, Kitayama M, Nakashima K. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations. Acta Neurol Scand 2008;117:255-259.
27. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125:391-403.
28. Papapetropoulos S, McCorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. Parkinsonism Relat Disord 2006;12:253-256.
29. Yamamoto R, Iseki E, Murayama N, et al. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. J Neurol Sci 2006;246:95-101.
30. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Correlations between gray matter reductions and cognitive deficits in dementia with lewy bodies and Parkinson's disease with dementia. Mov Disord (in press).
31. American Psychiatric Association. Manual diagnostico y estadistico de los trastornos mentales, Cuarta edición revisada, DSMIV-TR, 2003 ed. Barcelona: Masson; 2003.
32. Dufouil C, Clayton D, Brayne C, et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology 2000;55:1609-1613.
33. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
34. Fahn S, Elton RL, UPDRS program members. Unified Idiopathic Parkinson's disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson's Disease, Vol 2. Florham Park, NJ.: Macmillan Health Care Information; 1987. p 153-164.
35. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
36. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
37. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
38. James M, Plant GT, Warrington E. Cortical Vision Screening Test (CORVIST). Pearson Education Ltd. Oxford, UK. 2001.
39. Perneczky R, Drzezga A, Boecker H, et al. Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies. Neurobiol Aging 2009;30:1420-1429.
40. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study. Mov Disord 2008;23:2335-2343.
41. Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 2007;64:984-988.
42. Lezak MD. Neuropsychological Assessment, Fourth ed. New York: Oxford University Press; 2004.
43. Matsui H, Nishinaka K, Oda M, et al. Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations. Mov Disord 2006;21:2140-2144. (Pubitemid 46140426)
44. Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-1416.
45. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 2005;252:1345-1352.
46. Goldberg KB, Goldberg RE. Is seeing believing? Visual hallucinations in age-related macular degeneration and Charles Bonnet. J Ophthalmic Nurs Technol 2000;19:39-42.
47. Picton TW, Stuss DT, Alexander MP, Shallice T, Binns MA, Gillingham S. Effects of focal frontal lesions on response inhibition. Cereb Cortex 2007;17:826-838.
48. Blackwood NJ, Howard RJ, ffytche DH, Simmons A, Bentall RP, Murray RM. Imaging attentional and attributional bias: an fMRI approach to the paranoid delusion. Psychol Med 2000;30:873-883.